Background This is an updated version of a previously published review in The Cochrane
Library (2005, Issue 2) on'Megestrol acetate for the treatment of anorexia‐cachexia …

Answer questions and earn CME/CNE Advances in genomics and molecular biology have
identified aberrant proteins in cancer cells that are attractive targets for cancer therapy …

About half of all cancer patients show a syndrome of cachexia, characterized by anorexia
and loss of adipose tissue and skeletal muscle mass. Cachexia can have a profound impact …

Malnutrition, anorexia and cachexia are a common finding in cancer patients. They become
more evident with tumor growth and spread. However, the mechanisms by which they are …

Background Physicians are often asked about complementary therapies by patients with
cancer, and data show that the interest in and use of these therapies among patients with …

A high metabolic rate in myeloproliferative disorders is a common complication of
neoplasms, but the underlying mechanisms are incompletely understood. Using three …

Background Colon cancer (CC) patients commonly suffer declines in muscle mass and
aerobic function. We hypothesised that CC would be associated with reduced muscle mass …

Aims and background The optimal treatment of cancer cachexia remains unknown. In this
study, we compared the efficacy of three different treatment modalities in the management of …

TNF‐α was shown to stimulate mitogenicity in C2C12 myoblasts. Selected cytokines TNF‐α,
IFNα, or IFNγ reduced the expression of myosin heavy chain (MyHC IIa) when given …

Compelling evidence indicates that polyphenolic antioxidants show protective effects
against diabetic complications. We investigated the effects of a polyphenolic compound, 7-O …